[{"Assets_0_Q3_USD":59441000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":10049000000.0,"NetIncomeLoss_1_Q3_USD":1884000000.0,"NetIncomeLoss_3_Q3_USD":5081000000.0,"StockholdersEquity_0_Q3_USD":-8226000000.0,"EarningsPerShareBasic_1_Q3_USD":1.27,"EarningsPerShareBasic_3_Q3_USD":3.41,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1481000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1480000000.0,"Ticker":"ABBV","CIK":"1551152","name":"ABBVIE INC.","OfficialName":"AbbVie Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"276158647867.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"SP500","filed":"20191106"}]